PrimeRFP SCOUT · Federal Contract Recompete Brief

75D30124C19913TB management support — Siris Pharmaceutical Services LLC

Siris Pharmaceutical Services LLC holds $1.6M across 2 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 2 offers. Set-aside status: SBA. Recompete timing centers on the Sep 11, 2027 PoP end — agencies typically plan 12–18 months ahead.

Cdc Office Of Acquisition Services

Awarding office

Siris Pharmaceutical Services LLC

Recipient

Sep 11, 2027

PoP end

$1.4M

Obligated

$2.4M

Potential

493190

NAICS

R408

PSC

SBA

Set-aside

2 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Siris Pharmaceutical Services LLC — $90

Contract facts

SBA

Contract number75D30124C19913

AgencyCdc Office Of Acquisition Services

Awarding officeCdc Office Of Acquisition Services

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentSiris Pharmaceutical Services LLC

CAGE7D4M1

UEIDUZJNE5D4NF5

NAICS493190

No full NAICS 493190 intel page yet. Browse NAICS intelligence

PSCR408

Place of performanceATLANTA GA

Pricing typeTime And Materials

Extent competedCompeted Under SAP

Related solicitation75D301-24-R-73094

PoP startSep 9, 2024

PoP end (current)Sep 11, 2027

Obligated$1.4M

Current value$1.4M

Potential value$2.4M

TUBERCULOSIS (TB) CLINICAL TRIALS MANAGEMENT SUPPORT is a federal SBA award for Cdc Office Of Acquisition Services held by Siris Pharmaceutical Services LLC. Estimated value $2.4M ($1.4M obligated). Current period of performance ends Sep 11, 2027. Last award drew 2 bidders. Place of performance: ATLANTA GA. Related solicitation 75D301-24-R-73094.

TUBERCULOSIS (TB) CLINICAL TRIALS MANAGEMENT SUPPORT

Recompete timing

Public

● Expiring in 369 days

Current PoP ends Sep 11, 2027 (369 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Incumbent footprint

Public record

Siris Pharmaceutical Services LLC — $1.6M obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$1.6M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75D30124C19913?

75D30124C19913 (TB management support) is a Cdc Office Of Acquisition Services award with a potential value of $2.4M, currently held by Siris Pharmaceutical Services LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75D30124C19913?

Cdc Office Of Acquisition Services awarded 75D30124C19913 to Siris Pharmaceutical Services LLC (potential $2.4M).

Who is the incumbent on 75D30124C19913?

Siris Pharmaceutical Services LLC is the incumbent with $1.6M across 2 related awards in SCOUT’s public footprint. The current period of performance ends Sep 11, 2027.

When does Siris Pharmaceutical Services LLC’s 75D30124C19913 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 11, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75D30124C19913 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Jul 20, 2026